Botox Research Today is a free monthly online journal that collates and summarizes the latest research about Botox, including details on cosmetic botox, side-effects, alternatives, treatment.

Volume 2 (2005), Issue 4 (April)

1. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
   Curr Med Res Opin, 21(3): 433-8. [Abstract] [Full-text]
2. Induction of acute lung injury after intranasal administration of toxin botulinum a complex.
   Toxicol Pathol, 33(3): 336-42. [Abstract] [Full-text]
3. Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: long-term results of a prospective randomized clinical and manometric study.
   Am J Surg, 189(4): 429-34. [Abstract] [Full-text]
4. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
   Disabil Rehabil, 27(4): 176-84. [Abstract] [Full-text]
5. Long-term results of botulinum toxin for the treatment of chronic anal fissure: prospective clinical and manometric study.
   Int J Colorectal Dis, 20(3): 267-71. [Abstract] [Full-text]
6. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence.
   Eur Urol, 47(5): 653-9. [Abstract] [Full-text]
7. Botox therapy for refractory chronic migraine.
   Headache, 45(4): 355-7. [Abstract] [Full-text]
8. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
   Headache, 45(4): 315-24. [Abstract] [Full-text]
9. Duration of migraine is a predictor for response to botulinum toxin type A.
   Headache, 45(4): 308-14. [Abstract] [Full-text]
10. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Headache, 45(4): 293-307. [Abstract] [Full-text]
11. Clostridium botulinum type A progenitor toxin binds to Intestine-407 cells via N-acetyllactosamine moiety.
    Biochem Biophys Res Commun, 331(2): 571-6. [Abstract] [Full-text]

© 2004-2008 Botox Research Today. All Rights Reserved.